Results 181 to 190 of about 15,538 (356)

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real‐World International Experience

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Sutimlimab is a monoclonal antibody against complement fraction C1s approved for the treatment of hemolytic anemia due to cold agglutinin disease (CAD). Here, we analyzed and report the largest international CAD cohort of sutimlimab‐treated patients ever reported to highlight its safety and effectiveness in the real‐world setting. We accrued a
Bruno Fattizzo   +38 more
wiley   +1 more source

User experience and hemostatic efficacy: Comparative analysis of commercial agents in junctional and hepatic hemorrhage models. [PDF]

open access: yesPLoS One
Patterson K   +13 more
europepmc   +1 more source

Peripheral Blood Erythrophagocytosis in Plasmodium falciparum Malaria

open access: yes
American Journal of Hematology, EarlyView.
Teresa Almeida, Cristina Avelar Ferreira
wiley   +1 more source

The Role of Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma With Renal Impairment: A Systematic Review

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Renal impairment (RI), defined as estimated glomerular filtration rate less than 60 mL/min with or without the need for dialysis, is a frequent and severe complication in patients with relapsed/refractory multiple myeloma (RRMM), as it can affect patient prognosis, drug metabolism and treatment options.
Ioannis Ntanasis‐Stathopoulos   +7 more
wiley   +1 more source

Hemostatic and hematological profiles of horses with natural occurrence large colon impaction and medically treated

open access: green, 2016
Edmilson Rodrigo Daneze   +6 more
openalex   +2 more sources

Interfollicular Plasmacytosis and Hyperplastic Germinal Centers in Idiopathic Multicentric Castleman Disease, Idiopathic Plasmacytic Lymphadenopathy Subtype

open access: yes
American Journal of Hematology, EarlyView.
Stephanie Quon   +5 more
wiley   +1 more source

A Novel Plasma Heme Assay Reveals Disease Severity in Beta‐Thalassemia and Sickle Cell Anemia

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Anemia results from imbalanced hemoglobin or red blood cell production and clearance. Hemolytic anemia, caused by premature red blood cell removal, can be intravascular (in blood) or extravascular (erythrophagocytosis). Hemolysis is common in Sickle Cell Disease (SCD) and Beta‐Thalassemia anemia (β‐thalassemia), the most prevalent inherited ...
Laurent Kiger   +14 more
wiley   +1 more source

Development of a 50% (w/v) aluminium chloride hexahydrate solution as haemostatic agent. [PDF]

open access: yesEur J Hosp Pharm
Briot C   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy